Matching placebo to IMP clinical trials

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety deucravacitinib in patients with chronic hand eczema

This study is testing a new unapproved medicine called deucravacitinib for people with long-lasting hand eczema. We want to see if it helps reduce the eczema and if it's safe to use, compared to a dummy pill.